KRISHI
ICAR RESEARCH DATA REPOSITORY FOR KNOWLEDGE MANAGEMENT
(An Institutional Publication and Data Inventory Repository)
"Not Available": Please do not remove the default option "Not Available" for the fields where metadata information is not available
"1001-01-01": Date not available or not applicable for filling metadata infromation
"1001-01-01": Date not available or not applicable for filling metadata infromation
Please use this identifier to cite or link to this item:
http://krishi.icar.gov.in/jspui/handle/123456789/81577| Title: | Peste des petits ruminants (PPR) vaccine R&D investment: financial assessment of vaccine development and administration In India |
| Other Titles: | Not Available |
| Authors: | Govindaraj G Naveenkumar GS Balamurugan V Shome BR Roy P |
| ICAR Data Use Licennce: | http://krishi.icar.gov.in/PDF/ICAR_Data_Use_Licence.pdf |
| Author's Affiliated institute: | ICAR::National Institute of Veterinary Epidemiology and Disease Informatics Tamil Nadu Veterinary and Animal Sciences University, Madhavaram Milk Colony, Tamil Nadu, India |
| Published/ Complete Date: | 2023-05-31 |
| Project Code: | Not Available |
| Keywords: | gross technology revenue India Peste des Petits Ruminants research & development impact vaccine technology |
| Publisher: | Japanese Society of Veterinary Science |
| Citation: | 11. Govindaraj, G., Naveenkumar, G.S., Balamurugan, V., Shome, B.R. and Roy, P. (2023). Peste des petits ruminants (PPR) vaccine R&D investment: financial assessment of vaccine development and administration In India. Journal of Veterinary Medical Science. 85(7): 755-762. |
| Series/Report no.: | Not Available; |
| Abstract/Description: | The present study assessed the financial viability of Peste des Petits Ruminants (PPR) vaccine Research & Development (R&D) investment in India and the Gross Technology Revenue (GTR) accrual to the different stakeholders. The Net Present Value (NPV), Internal Rate of Return (IRR) and Benefit Cost Ratio (BCR) of PPR vaccine development and administration were USD 16,326.6 million (INR 130,612 crore), USD 18,454.2 million (INR 147,633 crore) and USD 21,645.6 million (INR 173,164 crore); 162.2%, 167.6% and 169.7% and 43.3:1, 48.8:1 and 57.1:1, respectively under low, medium and high disease incidence scenarios. The estimated cumulative GTR accrued during 2001–02 to 2017– 18 by the innovating public research institutions (Indian Council of Agricultural Research-Indian Veterinary Research Institute (ICAR-IVRI) and Tamil Nadu Veterinary and Animal Sciences University (TANUVAS)), private vaccine producers, public sector biologicals and government revenues in terms of taxes was USD 0.696 million (INR 5.568 crore) for ICAR-IVRI and USD 0.033 million (INR 0.26 crore) for TANUVAS; USD 5.00 million (INR 40 crore); USD 7.141 million (INR 57.1 crore) and USD 0.671 million (INR 5.36 crore), respectively. Overall, financial benefits of PPR vaccine development and administration to control PPR in India outweighs the investment in manifolds |
| Description: | Not Available |
| ISSN: | 0916-7250 |
| Type(s) of content: | Research Paper |
| Sponsors: | Not Available |
| Language: | English |
| Name of Journal: | Journal of Veterinary Medical Science |
| Journal Type: | Included NAAS journal list |
| NAAS Rating: | 7.20 |
| Impact Factor: | 1.20 |
| Volume No.: | 85(7) |
| Page Number: | 755-762 |
| Name of the Division/Regional Station: | Not Available |
| Source, DOI or any other URL: | doi: 10.1292/jvms.23-0021 |
| URI: | http://krishi.icar.gov.in/jspui/handle/123456789/81577 |
| Appears in Collections: | AS-NIVEDI-Publication |
Files in This Item:
There are no files associated with this item.
Items in KRISHI are protected by copyright, with all rights reserved, unless otherwise indicated.